http://www.editasmedicine.com
Editas Medicine, Inc. Company Intro
Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.
Industry
Healthcare
Editas Medicine, Inc. Headquaters
11 Hurley Street
Cambridge,02141
United States
Editas Medicine, Inc. Share price
14 Sep 2022 09:07 GMT
$15.25
-0.74 (-4.63 %)
Editas Medicine, Inc. Market cap
$1.013 B
WMC RANKING
2022
Editas Medicine, Inc. # 158
BiotechnologyLatest Editas Medicine, Inc. News
02 Oct 2022
Growth in Cell and Gene Therapy Market
Sept. 13, 2022. Sana Biotechnology, Our Science, sana.com, accessed Sept. 19, 2022; Editas Medicine, Our Research and. Pipeline, Editasmedicine.com...
02 Oct 2022
Growth in Cell and Gene Therapy Market
Sept. 13, 2022. Sana Biotechnology, Our Science, sana.com, accessed Sept. 19, 2022; Editas Medicine, Our Research and. Pipeline, Editasmedicine.com...
01 Oct 2022
Prime Medicine Stock: A Gene Editing IPO
He is also expected to retain his position and affiliation with the Broad Institute, Inc., Howard Hughes Medical Institute and Harvard University. Credit: Prime...
WMC Market Score
WMC Market to Revenue Score
Editas Medicine, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Editas Medicine, Inc. | USD | $91,508 | $236,615 | $-134,980 | $10,130B | 158 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Editas Medicine, Inc. Social Followers vs Top 4 Industry Competitors
Editas Medicine, Inc. Post vs Top 4 Industry Competitors
Editas Medicine, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Editas Medicine, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Editas Medicine, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Editas Medicine, Inc. | 0.99 | 8.78 | 0.00 | 0 | 0 | 0 | 3.96 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
